| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | PDE5 inhibitors enhance celecoxib killing in multiple tumor types. | J Cell Physiol | 2015 | 0.99 |
| 2 | GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human disease. | J Cell Physiol | 2015 | 0.98 |
| 3 | Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary cancer cells. | Mol Pharmacol | 2013 | 0.95 |
| 4 | OSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood-Brain Barrier: Implications for Anti-Cancer Therapies. | J Cell Physiol | 2015 | 0.94 |
| 5 | Regulation of dimethyl-fumarate toxicity by proteasome inhibitors. | Cancer Biol Ther | 2014 | 0.88 |
| 6 | Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation. | Atherosclerosis | 2006 | 0.83 |
| 7 | Differential regulation of autophagy and cell viability by ceramide species. | Cancer Biol Ther | 2015 | 0.79 |
| 8 | HSPA5/Dna K may be a useful target for human disease therapies. | DNA Cell Biol | 2015 | 0.75 |